Development and validation of novel approaches for protection from drug-induced hearing loss

Category

Thesis advisor:

GND

128643250

ORCID

0000-0003-2743-0070

Schambach, Axel;

GND

138520429

Galla, Melanie;

GND

106432584X

ORCID

0000-0002-0348-3015

Staecker, Hinrich;

GND

122057090

ORCID

0000-0001-8071-1379

Hühn, Jochen

Host institution:

GND

2019538-2

Medizinische Hochschule Hannover 17.05.1965 -;

GND

10186552-1

Hannover Biomedical Research School 2003 -;

GND

1026380278

Medizinische Hochschule Hannover Institut Experimentelle Hämatologie;

Date accepted:

2024

Date Issued:

2024

DOI:

10.26068/mhhrpm/20240919-001

PPN:

1902914805

Language:

English

Type of Resource:

Text

Extent:

2 ungezählte Blätter, 138 Blätter

Place Term:

Hannover

Place of Origin:

Hannover

Publisher (creation):

Medizinische Hochschule

Keywords:

Hearing loss; Ototoxicity; Cisplatin; Neomycin; Anti-apoptotic; Caspase inhibitor

DDC subject of DNB:

610 Medical sciences Medicine

Library shelfmark::

D 83319

Hosting institution:

Hospitals and Institutes, Institute of Experimental Hemalogy

publications:

Enthält 2 Zeitschriftenaufsätze aus "Molecular Therapy Nucleic Acids”, Jg. 35 (2024) und „Journal of Molecular Medicine”, Jg. 102 (2024)

statement of responsibility:

by Larissa Nassauer, M.Sc. Biomedicine ; Hannover Medical School, International PhD Program “Molecular Medicine” at Hannover Biomedical Research School (HBRS), Institute of Experimental Hematology ; Supervisor: Prof. Dr. med. Axel Schambach, PhD, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany; Scientific supervisor: Dr. rer. nat. Melanie Galla, Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany; Co-supervisors: Prof. Hinrich Staecker, MD, PhD Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, US; Prof. Dr. rer. nat. Jochen Hühn, Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany